About Bioject
Bioject is a company based in Tigard (United States) founded in 1985 was acquired by Inovio Pharmaceuticals in March 2016. Bioject operates in a competitive market with competitors including Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others.
- Headquarter Tigard, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioject Medical Technologies Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$994.55 K (USD), Post-IPO
Jan 24, 2013
- Investors
-
Employee Count
Not available
-
Acquired by
Inovio Pharmaceuticals
(Mar 14, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bioject
Investors in Bioject
Bioject has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Inovio Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of vaccines for the treatment of cancer and infectious diseases
|
Locked | Locked | Locked |
Investor details for Bioject
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioject
Investment portfolio details for Bioject
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioject
Detailed financials for Bioject
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioject Comparisons
Peer comparison for Bioject
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioject
Bioject operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ensysce, Oxular, Arecor, EryDel and PharmaJet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| Locked | Locked | Locked |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| Locked | Locked | Locked |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| Locked | Locked | Locked |
Erythrocyte encapsulation systems for drug delivery are developed.
|
|
| Locked | Locked | Locked |
Provider of needle-free injection technology
|
|
| Locked | Locked | Locked |
Provider of a proprietary platform for gene therapy
|
Detailed competitors of Bioject
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioject
Complete news archive for Bioject
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioject
Bioject was founded in 1985 and raised its 1st funding round 20 years after it was founded.
Bioject is headquartered in Tigard, United States. It is registered at Tigard, Oregon, United States.
Bioject Medical Technologies develops needle-free injection therapies (NFITS). The companys technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. The company claims that this creates an ultra-fine stream of fluid that penetrates the skin and delivers medication in a fraction of a second. Products include: Bioject 2000 Needle Free Injection System (to deliver intramuscular injections); ZetaJet (for subcutaneous or intramuscular injections); Drug Reconstitution System (connector to withdraw medication from a vial without using a needle); and Free Vial Adapter (plastic device to replaces a fill needle).
Bioject's top competitors include Oxular, PharmaJet and Splice Bio.
Bioject has 1 investor. Key investors include Inovio Pharmaceuticals.